OSI PHARMACEUTICALS INC
Healthcare · In Vitro & In Vivo Diagnostic Substances · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Material events
SEC Form 8-K · most recent- Debt acceleration / triggering event · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsJun 9, 2010
- Entered a material agreement · Modified shareholder rights · Other material eventMay 17, 2010
- Results of operations · Other material eventApr 22, 2010
- Other material eventApr 15, 2010
- Entered a material agreement · Director / officer change · Other material eventApr 6, 2010
- Other material eventMar 24, 2010
- Other material eventMar 3, 2010
- Other material eventMar 1, 2010
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AFeb 14, 2011
- CT ORDEROct 19, 2010
- SC TO-I/ASCHEDULE TO, AMENDMENT NO. 4Aug 5, 2010
- SC TO-I/AJul 13, 2010
- SC 13G/ASEC FILINGJul 12, 2010
- UPLOADJul 2, 2010
- SC TO-I/AJun 29, 2010
- UPLOADJun 24, 2010
- SC TO-I/AJun 18, 2010
- 15-12GJun 18, 2010
- SC TO-IJun 17, 2010
- EFFECTJun 14, 2010
- EFFECTJun 14, 2010
- EFFECTJun 14, 2010
- EFFECTJun 14, 2010
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.